(Q37799036)

English

A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology

scientific article published on June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

pathophysiology

1 reference

based on heuristic

inferred from title

aneurysmal subarachnoid hemorrhage

1 reference

based on heuristic

inferred from title

Nicolas M. Orsi

object named as

Nicolas M Orsi

2

0 references

author name string

Yahia Z Al-Tamimi

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Audrey C Quinn

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Shervanthi Homer-Vanniasinkam

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Stuart A Ross

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

World Neurosurgery

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

654-667

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

RUPTURED INTRACRANIAL ANEURYSMS--THE ROLE OF ARTERIAL SPASM.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endothelin receptor antagonists and cerebral vasospasm: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Oxidation of bilirubin produces compounds that cause prolonged vasospasm of rat cerebral vessels: a contributor to subarachnoid hemorrhage-induced vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Inhibition of vasospasm with lymphocyte function-associated antigen-1 monoclonal antibody in a femoral artery model in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

INTRACRANIAL ANEURYSM OF THE INTERNAL CAROTID ARTERY: CURED BY OPERATION

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Microvascular responses to cerebral ischemia/inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm"

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Observations on the Effect of Systemic Blood Pressure on Intracranial Circulation in Patients with Cerebrovascular Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Postoperative hemodynamic and metabolic changes in patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

The impact of balloon angioplasty on the evolution of vasospasm-related infarction after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Increases in Cardiac Output Can Reverse Flow Deficits from Vasospasm Independent of Blood Pressure: A Study Using Xenon Computed Tomographic Measurement of Cerebral Blood Flow

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

D-dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cerebral blood flow in subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endothelin-1 in plasma, cisternal CSF and microdialysate following aneurysmal SAH.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cytokine production in cerebrospinal fluid after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Advances in vasospasm treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Postoperative hypertension in the management of patients with intracranial arterial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Oxidative degradation of bilirubin produces vasoactive compounds

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

The Utility and Benefits of External Lumbar CSF Drainage after Endovascular Coiling on Aneurysmal Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cerebral autoregulation testing after aneurysmal subarachnoid hemorrhage: the phase relationship between arterial blood pressure and cerebral blood flow velocity

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Complement activation in the central nervous system following blood-brain barrier damage in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

The role of inflammation in CNS injury and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Delayed cerebral ischaemia: The pathological substrate

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Interleukin-6 and development of vasospasm after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Neurovascular protection reduces early brain injury after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Serum immunocomplexes in patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Hemostasis and fibrinolysis activation after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: a preliminary observation

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Calcium antagonists for aneurysmal subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Cerebral lesions due to intracranial aneurysms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Delayed ischaemia after subarachnoid haemorrhage: a role for small vessel changes

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

A study of possible correlation between subarachnoid haemorrhage related vasospasm and the post-bleed blood platelet count chart in a Caucasian population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Analysis of Intrathecal Interleukin-6 As a Potential Predictive Factor for Vasospasm in Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Vasoconstrictive neurovascular coupling during focal ischemic depolarizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

SUBARACHNOID HEMORRHAGE--FACTORS IN PROGNOSIS AND MANAGEMENT

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Increased levels of nitrite/nitrate in the cerebrospinal fluid of patients with subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Hypomagnesemia after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Focal laminar cortical infarcts following aneurysmal subarachnoid haemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Time course of vasospasm in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Acute systemic inflammatory response syndrome in subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Role of p53 and apoptosis in cerebral vasospasm after experimental subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Endovascular management of cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2010.02.005

7 January 2021

Identifiers

10.1016/J.WNEU.2010.02.005

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37799036&oldid=1728567689"